Order Levofloxacin Online - Australian Pharmacy

Levofloxacin, the active L‑enantiomer of ofloxacin, was approved for clinical use in 1996 and has since become one of the most widely prescribed fluoroquinolones. It demonstrates concentration‑dependent, bactericidal activity and achieves near‑complete oral bioavailability, with rapid distribution to the lungs, urinary tract, skin, and soft tissues. Its pharmacokinetic profile supports once‑daily dosing in many indications and a postantibiotic effect that extends the duration of bacterial suppression after drug concentrations fall below the MIC.

What Levofloxacin is

Levofloxacin is a broad‑spectrum fluoroquinolone antibiotic. It inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, disrupting DNA replication and transcription. It is active against many gram‑positive and gram‑negative organisms and concentrates in urine, lung parenchyma, skin, and soft tissues; its activity is diminished against organisms producing inducible chromosomal resistance and some anaerobes.

What it is used for

Indications include acute bacterial sinusitis, community‑acquired pneumonia, chronic bronchitis exacerbations, uncomplicated and complicated urinary tract infections, pyelonephritis, skin and soft‑tissue infections, and selected intra‑abdominal infections when susceptibility is favorable. It provides an oral option when parenteral therapy is needed, and is preferred in certain prior antibiotic‑exposed infections where Gram‑negative pathogens predominate.

Contraindications and precautions

Contraindications include known hypersensitivity to levofloxacin or other quinolones; concomitant use with tizanidine; pregnancy and lactation; and age under 18 years due to potential cartilaginous toxicity and impaired joint development. In patients with myasthenia gravis, use is cautioned as neuromuscular blockade can be exaggerated.

Precautions: Tendonitis and tendon rupture risk is elevated, especially in patients over 60, those on corticosteroids, or with a history of tendon disorders. Discontinue at first signs of tendon pain or swelling. QT interval prolongation may occur; avoid in congenital or acquired long QT syndromes, with QT‑prolonging drugs, or in electrolyte disturbances. Caution in hepatic or renal impairment; adjust dosing for CrCl <50 mL/min and monitor for neuropsychiatric symptoms (anxiety, confusion, tremor, agitation). Hypoglycemia and hyperglycemia have been reported; monitor glucose in diabetic patients. Photosensitivity can occur; limit sun exposure and avoid tanning beds. Serious hypersensitivity reactions are rare but require immediate medical attention. Avoid use in patients with known Achilles tendon pathology related to quinolone exposure unless benefits outweigh risks.

Side effects by frequency

Very common (≥1/10): nausea, diarrhea, headache, dizziness, insomnia. Common (≥1/100 to <1/10): vomiting, abdominal pain, taste disturbance, rash, photophobia, fatigue. Uncommon (≥1/1,000 to <1/100): candidal infections, dizziness with vertigo, edema. Rare (≥1/10,000 to <1/1,000): tendinopathy or tendon rupture, liver enzyme elevations, severe cutaneous reactions. Very rare: anaphylaxis, hepatic failure, seizures. Discontinue immediately at signs of tendon pain or rupture; seek care for severe hypersensitivity or liver injury.

Interactions with other substances

Absorption is reduced by concomitant administration of divalent or trivalent cations (antacids, sucralfate, iron, calcium, magnesium, zinc); separate dosing by at least 2 hours before or 4 hours after levofloxacin. Theophylline and caffeine may augment CNS stimulation; monitor for agitation, tremor, or insomnia. QT‑prolonging drugs (certain antiarrhythmics, macrolides, phenothiazines) and electrolyte disturbances increase arrhythmia risk; correct abnormalities where feasible. NSAIDs can increase CNS excitability and seizure potential. Warfarin and other anticoagulants may have altered effects; monitor INR. Corticosteroids with fluoroquinolones increase tendon pathology risk. Use in pregnancy and lactation is discouraged unless no alternatives; counsel on risks and monitor for adverse outcomes. Avoid concomitant use with tizanidine due to hypotension and sedation risk.